Drug Resistance (TB)

"Pulmonary Tuberculosis (TB): Drug Resistance in HIV Infection in Rome, 1987-1996."

Published in AIDS Weekly, May 18th, 1998

According to an abstract submitted by the authors to the Sixth European Conference on Clinical Aspects and Treatment of HIV Infection, held October 11-15, 1997, in Hamburg, Germany, "Background of Study: HIV infection has been associated with increased rates of single- and multidrug-resistant (MDR) TB in Western countries. The emergence of MDR TB among patients with HIV infection has raised concern because of nosocomial outbreaks, high resistance to treatment, and high mortality rate. Objective: A retrospective study was performed in order to evaluate: a) global prevalence of drug resistant pulmonary TB to 4 drugs: Isoniazid (H), Rifampin (R), Ethambutol (E), and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1998-05-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry